PlainPharmaWatch

CMS Open Payments · Tool

Acumed LLC vs Sumitomo Pharma Co., Ltd.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Sumitomo Pharma Co., Ltd. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 2,292, versus 1,742 for the other company. Its single largest recorded recipient represents 0.4% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Acumed LLC
HHI 1,742 · top recipient 0.4%
Ranked #805 of 1,838 companies by HHI
Sumitomo Pharma Co., Ltd.
HHI 2,292 · top recipient 0.4%
Ranked #696 of 1,838 companies by HHI

Payment Overview

Company A

Acumed LLC

Total Payments
$3.5M
% of Industry
0.0%
Transactions
4,058
Avg per Transaction
$863.68
Recipients
4,053
Avg per Recipient
$864.74
Payment Types
8
Top Payment Type
Royalty or License
Total Payments
$3.5M
% of Industry
0.0%
Transactions
94
Avg per Transaction
$37.3K
Recipients
89
Avg per Recipient
$39.4K
Payment Types
5
Top Payment Type
Charitable Contribution

Highlighted values indicate the higher figure for each metric.

Total payments compared

Acumed LLC vs Sumitomo Pharma Co., Ltd. - total reported payments in CMS Open Payments PY2024

Acumed LLC$3.5MSumitomo Pharma Co., Ltd.$3.5M

Payment Types Breakdown

Acumed LLC

Royalty or License $2.0M

57.7%

Grant $372.7K

10.6%

Compensation for Services Other Than Consulting $343.5K

9.8%

Consulting Fee $255.6K

7.3%

Travel and Lodging $184.8K

5.3%

Food and Beverage $178.1K

5.1%

Sumitomo Pharma Co., Ltd.

Charitable Contribution $44.9K

1.3%

Travel and Lodging $40.9K

1.2%

Honoraria $21.0K

0.6%

Consulting Fee $14.5K

0.4%

Food and Beverage $555.57

0.0%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Acumed LLC

  1. 1

    SHAWN W O'DRISCOLL

    $1,369,858.35 · 17 txns

  2. 2

    Ohsu Hospital And Clinics

    $179,622.87 · 7 txns

  3. 3

    STEPHEN A SCHENDEL

    $159,279.71 · 2 txns

  4. 4

    ROY SANDERS

    $77,087.71 · 4 txns

  5. 5

    ROBIN N KAMAL

    $52,696.89 · 29 txns

Sumitomo Pharma Co., Ltd.

  1. 1

    Massachusetts Eye And Ear Infirmary

    $44,947.00 · 1 txns

  2. 2

    NAVAL G DAVER

    $31,482.90 · 17 txns

  3. 3

    ROHIT KULKARNI

    $14,830.31 · 9 txns

  4. 4

    AKIRA SAWA

    $7,021.03 · 33 txns

  5. 5

    John M. Kane

    $6,983.57 · 10 txns

Summary Comparison

Metric Acumed LLC Sumitomo Pharma Co., Ltd.
Total Payments $3.5M $3.5M
% of Industry Total 0.0% 0.0%
Transaction Count 4,058 94
Avg per Transaction $863.68 $37.3K
Recipient Count 4,053 89
Avg per Recipient $864.74 $39.4K
Payment Type Count 8 5
Top Payment Type Royalty or License Charitable Contribution

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.